Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037435 | SCV000061092 | benign | not specified | 2011-06-09 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on its high frequency in the general population (3%; LMM unpublished data). |
Prevention |
RCV000037435 | SCV000308816 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000242368 | SCV000317987 | benign | Cardiovascular phenotype | 2015-07-20 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Eurofins Ntd Llc |
RCV000037435 | SCV000342340 | benign | not specified | 2016-06-07 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000374719 | SCV000481605 | benign | Danon disease | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000280231 | SCV000481606 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000374719 | SCV000560062 | benign | Danon disease | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000716802 | SCV000847645 | benign | History of neurodevelopmental disorder | 2015-07-20 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
ARUP Laboratories, |
RCV000374719 | SCV001472973 | benign | Danon disease | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000675448 | SCV001873371 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000374719 | SCV000734732 | likely benign | Danon disease | no assertion criteria provided | clinical testing | ||
Mayo Clinic Laboratories, |
RCV000675448 | SCV000801130 | benign | not provided | 2015-10-20 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000037435 | SCV001917070 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037435 | SCV001927464 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037435 | SCV001956992 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037435 | SCV001973880 | benign | not specified | no assertion criteria provided | clinical testing | ||
Cohesion Phenomics | RCV000280231 | SCV003803624 | likely benign | Hypertrophic cardiomyopathy | 2022-09-29 | no assertion criteria provided | clinical testing |